News
A £1.1bn drug company is to quit the London Stock Exchange (LSE) as the troubled market battles an exodus of businesses.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback